RESUMO
Concentration of circulating immune complexes (CIC) and cytotoxicity (natural and antibody-dependent) of blood lymphocytes were studied in 52 patients at the developed stage of chronic myeloid leukemia (CML). Elevation of CIC level and reduction of cytotoxicity detectable in all CML patients were most manifest in those with high tumor mass and during exacerbation of the leukemia process. A conclusion has been made that CIC are suppressors of natural and antibody-dependent cytotoxicity of blood lymphocytes in CML patients.
Assuntos
Complexo Antígeno-Anticorpo/imunologia , Citotoxicidade Imunológica/imunologia , Células Matadoras Naturais/imunologia , Leucemia Mielogênica Crônica BCR-ABL Positiva/imunologia , Citotoxicidade Celular Dependente de Anticorpos/imunologia , Humanos , Tolerância Imunológica/imunologiaRESUMO
The concentration of circulating immune complexes, serum immunoglobulins and state of phagocytic function of neutrophils was studied in patients with autoimmune thrombocytopenic purpura. The patients showed a significant increase of the levels of circulating immune complexes, content of Ig M and Ig G, an increase of the phagocytic activity of neutrophils at the stage of migration, adhesion and absorption of the heterogeneous. The revealed disorders of phagocytic function and destruction of granulocytes at the stage of digestion may be explained by increased load on the phagocytic neutrophils due to the main pathologic process.
Assuntos
Complexo Antígeno-Anticorpo/sangue , Doenças Autoimunes/imunologia , Neutrófilos/imunologia , Fagocitose/imunologia , Púrpura Trombocitopênica/imunologia , Adulto , Feminino , Humanos , Imunoglobulinas/análise , Contagem de Leucócitos , Masculino , Pessoa de Meia-IdadeRESUMO
UNLABELLED: The authors studied the levels of large- and medium molecular circulating immune complexes (CIC) and immunoglobulins of main classes (Ig) in 17 patients with systemic lupus erythematosus (SLE) and 47 patients with rheumatoid arthritis (RA). RESULTS: low molecular CIC increased in 35.2% of patients with SLE and in 42.5% with RA; patients with SLE showed a significant reduction of IgA in 80.4%. The IgA/IgM ratio was significantly reduced in SLE due to the above finding. The IgA level remained unchanged in RA.